Evidence map›Paper›PMID 40873399›Full record

ArticleChemistry (Weinheim an der Bergstrasse, Germany)2025

Systematic Mapping of Homoserine Lactone and Cyclodextrin Binding Strengths - Effects of Structural Features.

Otso I V Luotonen, Rasmus Rantanen, Lijo George, Sandra Kaabel, Eduardo Anaya-Plaza, Mauri A Kostiainen

Abstract read
In one paragraph

Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Otso I V LuotonenDepartment of Bioproducts and Biosystems, Aalto University, Espoo, 0076 Aalto, Finland.ORCID https://orcid.org/0000-0001-9118-6493
Rasmus RantanenDepartment of Bioproducts and Biosystems, Aalto University, Espoo, 0076 Aalto, Finland.
Lijo GeorgeDepartment of Bioproducts and Biosystems, Aalto University, Espoo, 0076 Aalto, Finland.
Sandra KaabelCenter of Excellence in Life-Inspired Hybrid Materials (LIBER), Aalto University, Espoo, 0076 Aalto, Finland.
Eduardo Anaya-PlazaDepartment of Bioproducts and Biosystems, Aalto University, Espoo, 0076 Aalto, Finland.
Mauri A KostiainenDepartment of Bioproducts and Biosystems, Aalto University, Espoo, 0076 Aalto, Finland.ORCID https://orcid.org/0000-0002-8282-2379

Funding

Research Council of Finland
6 · The paper itself

Abstract

Directing the collective behavior of bacteria is important for various applications in chemical bioproduction, water treatment, and antibiofilm solutions. A potential approach to such control mechanisms lies in sequestering signal molecules (autoinducers) by macrocyclic host molecules that lower the effective concentration of the former, modulating bacterial signaling. Cyclodextrins (CD) - one of the best-established families of hosts - have been shown to bind homoserine lactones (HSL) acting as autoinducers, but with a focus limited to shorter (≤ 8 carbons) tailed molecules and β-CD. Here, we have systematically mapped binding affinities for HSLs of three different tail lengths and with different 3-site substituents (used for signal differentiation), with native and substituted α- and β-CDs. The HSL alkyl chain length has the most influence on affinity, although the 3-substitution also slightly affects the binding constant. Little difference between native CDs was observed, but the binding ability of α-CD was more susceptible to even minute substitutions. The wider β-CD core could be substituted with greater modularity without impairing HSL binding ability. The results constitute an initial chemical toolbox to be applied in guiding host design for HSL sequestering in, for example, therapeutic applications, but also in constructing systems for the modulation of bacterial collective behavior.

Indexed as

4-Butyrolactonebeta-CyclodextrinsCyclodextrinsBinding Sites4-Butyrolactonebeta-CyclodextrinsCyclodextrinshomoserine lactonecyclodextrinhomoserine lactonehost‐guest chemistrysupramolecular interactionsynthesis

Identifiers

PMID40873399
PMCPMC12587022

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.